A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
Open accessThe DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Abstract
Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs) have been commonly prescribed for depression treatment. However, their effects on blood pressure are unclear. Materials and methods: Effects on blood pressure of depressive patients in two groups (SSRIs versus placebo and SSRIs versus SNRIs) were evaluated. A search was conducted for double-blind, randomized controlled trials (RCTs) in PubMed, EMBASE, ISI Web of Science, PsycNET, CCRCT, and DARE (up to March 2017). The outcomes were systolic blood pressure (SBP) changes and diastolic blood pressure (DBP) changes from baseline to endpoint or to a certain period of treatment duration. Weighted mean differences (WMDs) and 95% CIs were calculated and pooled using random effects models. The χ 2 test and I 2 statistics were used to assess heterogeneity. Funnel plots, Begg’s test, and Egger’s test were used to estimate publication bias. Results: A total of 23 RCTs involving 13,285 participants were included. Patients on SSRIs showed no significant differences in blood pressure changes compared with placebo. In the group of SSRIs versus SNRIs, overall SBP changes and DBP changes revealed statistical significances (WMD 1.5 mmHg, 95% CI -2.15, -0.84, Z =4.46, P <0.00001 and WMD 1.34 mmHg, 95% CI -1.92, -0.75, Z =6.18, P <0.00001). Subgroup analyses on treatment duration and age further evidenced these findings. Conclusion: It was established that SSRIs did not affect blood pressure, while SNRIs led to a modest increase in SBP and DBP with statistical significance compared with SSRIs. Keywords: meta-analysis, blood pressure change, depression treatment, selective serotonin reuptake inhibitors, serotonin and noradrenaline reuptake inhibitors, depression, antidepressant, systolic blood pressure, diastolic blood pressure
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“2/1 mm Hg increase with SNRI (selective norepinephrine and serotonin reuptake inhibitors)”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased odds ratio of 3.19 of hypertension with tricyclic antidepressant”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“3/1 mm Hg increase with nonselective NSAIDs”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“NSAIDs can antagonize the effects of RAAS-inhibitors and beta blockers”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“No increase in blood pressure with aspirin”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [38]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Sertraline treatment of major depression in patients with acute MI or unstable angina.
Glassman, A., O’Connor, C., Califf, R., Swedberg, K., Schwartz, P., Bigger, J., Krishnan, K., van Zyl, L. V., Swenson, J., Finkel, M., et al. (2002) · Journal of the American Medical Association (JAMA) · doi:10.1016/s1062-1458(02)00908-x · Cited by 1,494 · cited 1×
“One study included patients with MDD combined with a history of acute myocardial infarction or unstable angina.(20) Two trials were about MDD combined with coronary artery disease(28) or depressive disorders combined with acute coronary syndrome,(33) respectively.”
Sertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Kemp, A. H., Quintana, D. S., Gray, M. A., Felmingham, K. L., Brown, K., & Gatt, J. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.012 · Cited by 1,286 · cited 2×
“Depression is associated with reductions in heart rate variability(42) and might be related to low cardiac vagal control,(43) as well as central autonomic dysfunction, a shift of autonomic balance toward sympathetic predominance, leading to cardiovascular somatic symptoms of depression such as higher heart rate and BP…”
Kario, K., Pickering, T. G., Umeda, Y., Hoshide, S., Hoshide, Y., Morinari, M., Murata, M., Kuroda, T., Schwartz, J. E., & Shimada, K. (2003) · Circulation · doi:10.1161/01.cir.0000056521.67546.aa · Cited by 1,250 · cited 1×
“Prior studies have shown that a higher morning BP surge is positively correlated with depressive symptoms(54) and is associated with stroke risk independently in older hypertensive patients.(55) Low-frequency component of systolic BPV, a surrogate of sympathetic vasomotor tone, can show blunted response with depressiv…”
Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., Vitiello, B., Ritz, L., Iyengar, S., Abebe, K., et al. (2008) · JAMA · doi:10.1001/jama.299.8.901 · Cited by 700 · cited 1×
“26 Emslie et al 2014 29,a Emslie et al 2014 29 , b Emslie et al 2015 30 Atkinson et al 2014 40 Oslin et al 2003 24”
Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., et al. (2007) · JAMA · doi:10.1001/jama.297.4.367 · Cited by 658
Depression and the Link with Cardiovascular Disease
Dhar, A. K., & Barton, D. A. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00033 · Cited by 400 · cited 2×
“Depression deregulates hypothalamic–pituitary–adrenal axis when depressive people are experiencing psychological stress.(2) As SSRIs and SNRIs improve the stressful condition, we speculate that they can play a role in hypothalamic–”
Cohen, H. W., Gibson, G., & Alderman, M. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00301-0 · Cited by 390 · cited 1×
“It is reported that SSRIs can affect cardiovascular function.(16) SSRIs are rarely associated with cardiac death but cause side effects such as hypotension and mild bradycardia.”
Cited by
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
2020 International Society of Hypertension global hypertension practice guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283
Mazereel, V., Detraux, J., Vancampfort, D., van Winkel, R., & De Hert, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573479 · Cited by 205
Zhang, M., Chen, J., Yin, Z., Wang, L., & Peng, L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01759-z · Cited by 172
Self-citationContaminants of emerging concern in freshwater fish from four Spanish Rivers
Pico, Y., Belenguer, V., Corcellas, C., Diaz-Cruz, M. S., Eljarrat, E., Farré, M., Gago-Ferrero, P., Huerta, B., Navarro-Ortega, A., Petrovic, M., et al. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2018.12.366 · Cited by 154
Antidepressant Drugs Effects on Blood Pressure
Calvi, A., Fischetti, I., Verzicco, I., Murri, M. B., Zanetidou, S., Volpi, R., Coghi, P., Tedeschi, S., Amore, M., & Cabassi, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.704281 · Cited by 175
“89 mmHg of diastolic BP) (117–119); a marked increase in BP levels was reported when supratherapeutic doses were used (+12 mmHg for systolic BP and +7 mmHg for diastolic BP) (90).”
BackgroundMatraszek, R., Chwil, M., Terlecka, P., & Skoczylas, M. M. (2019) · Pharmaceuticals · doi:10.3390/ph12040172 · Cited by 50
The Effects of Pain and Analgesic Medications on Blood Pressure
Rivasi, G., Menale, S., Turrin, G., Coscarelli, A., Giordano, A., & Ungar, A. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01205-5 · Cited by 50
Foy, M. C., Vaishnav, J., & Sperati, C. J. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.013 · Cited by 45
Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale
Manolis, T. A., Manolis, A. S., & Manolis, A. S. (2018) · Angiology · doi:10.1177/0003319718780145 · Cited by 41
Fugger, G., Dold, M., Bartova, L., Kautzky, A., Souery, D., Mendlewicz, J., Serretti, A., Zohar, J., Montgomery, S., Frey, R., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.03.005 · Cited by 34
Anxiety disorders and age-related changes in physiology
Mutz, J., Hoppen, T. H., Fabbri, C., & Lewis, C. M. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.189 · Cited by 28
Off-Target Effects of Antidepressants on Vascular Function and Structure
Dimoula, A., Fotellis, D., Aivalioti, E., Delialis, D., Polissidis, A., Patras, R., Kokras, N., & Stamatelopoulos, K. S. (2021) · Biomedicines · doi:10.3390/biomedicines10010056 · Cited by 22
“Moreover, there was no significant difference among the five main SSRI drugs [105].”
BackgroundResultPsychopharmacology of Williams syndrome: safety, tolerability, and effectiveness
Thom, R. P., Pober, B. R., & McDougle, C. J. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1867535 · Cited by 23
“A meta-analysis demonstrated that the increase in blood pressure is <3 mmHg, and therefore unlikely to be relevant in normotensive patients [69].”
BackgroundManagement of vasomotor symptoms in cancer patients
Zhu, L., Hshieh, T. T., Iyer, T. K., Morgans, A. K., & Hamnvik, O. R. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf002 · Cited by 23
Obas, K. A., Kwiatkowski, M., Schaffner, E., Lang, U. E., Stolz, D., Eze, I. C., Imboden, M., & Probst-Hensch, N. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-09396-2 · Cited by 19
Identifying and Managing Anxiety Disorders in Primary Care
Brahmbhatt, A., Richardson, L. G., & Prajapati, S. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.10.019 · Cited by 18
A single oral dose of citalopram increases interoceptive insight in healthy volunteers
Livermore, J., Holmes, C. L., Moga, G., Adamatzky, K., Critchley, H., Garfinkel, S., & Campbell-Meiklejohn, D. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06115-7 · Cited by 10
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?
Durcan, R., O’Callaghan, C., & Rowe, J. B. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf310 · Cited by 15
Murala, S., & Bollu, P. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-07897-2_9 · Cited by 17
Ahmadimanesh, M., Balarastaghi, S., Rashedinia, M., & Yazdian‐Robati, R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05550-8 · Cited by 15
Depressive Symptoms and Blood Pressure: A Cross-Sectional Study of Population Data
Montaño, D. (2019) · Journal of Psychophysiology · doi:10.1027/0269-8803/a000242 · Cited by 12
Frayne, J. S., Watson, S., Snellen, M., Nguyen, T., & Galbally, M. (2021) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.02.002 · Cited by 12
Treatment resistant depression in elderly
Wang, S.-C., Yokoyama, J. S., Tzeng, N., Tsai, C.-F., & Liu, M. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.02.004 · Cited by 14
Chen, R., Amirghasemi, F., Ma, H., Ong, V., Tran, A., & Mousavi, M. P. S. (2023) · ACS Sensors · doi:10.1021/acssensors.3c01545 · Cited by 10
Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Mareti, Ε., Ampatzi, C., Paschou, S. Α., Voziki, E., & Goulis, D. G. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180911104942 · Cited by 9
Perinatal Depression Treatment Guidelines for Obstetric Providers
Higgins, N. E., Rose, M. J., Gardner, T. J., & Crawford, J. N. (2023) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2023.03.009 · Cited by 7
Hypertension in Association With Anxiety and Depression – A Narrative Review
Ivanušić, J., & Degmečić, D. (2022) · Southeastern European medical journal · doi:10.26332/seemedj.v6i1.216 · Cited by 4
Niazi, S. K., Memon, S. H., Lesser, E. R., Brennan, E. R., & Aslam, N. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14311 · Cited by 4
The risk of a blood pressure increase during treatment with selected psychotropic drugs
Romańczyk, M., Surma, S., Kocyan, B., Kłos, K., Strona, W., & Krzystanek, M. (2022) · Arterial Hypertension · doi:10.5603/ah.a2021.0015 · Cited by 3
Licht-Ardila, M., Romero, L. A., & Vallejo-Ardila, D. L. (2022) · Revista Colombiana de Cardiología · doi:10.24875/rccar.21000078 · Cited by 7
Tajeu, G. S., Wu, J., Tewksbury, C. M., Spitzer, J. C., Rubin, D. J., Gadegbeku, C. A., Soans, R. S., Allison, K. C., & Sarwer, D. B. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.10.004 · Cited by 2
Weggen, J. B., Darling, A. M., Autler, A. S., Hogwood, A. C., Decker, K., Richardson, J. W., Tuzzolo, G., & Garten, R. S. (2024) · Experimental Physiology · doi:10.1113/ep091762 · Cited by 2
Zhu, H., Pan, L., Lui, H., & Zhang, J. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70029 · Cited by 2
Psychopharmacology for Pediatric Depressive Disorders
Rengasamy, M. L., Shalev, A., & Birmaher, B. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_16 · Cited by 2
Петрова, Н. Н., Semenova, N. V., & Malyshko, L. V. (2024) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2024-1033 · Cited by 1
Hospital Discharge Prescription of Drugs That May Raise Blood Pressure in Patients With Hypertension
Miyake, S., Miyawaki, A., Matsui, H., Kimura, Y., & Yasunaga, H. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70150 · Cited by 1
Depression, anxiety, and quality of life
Gao, K., & Zhang, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00016-7 · Cited by 2
Breder, C. V., CRUZ, I. S., & de Freitas, O. G. A. (2023) · Revista Científica Semana Acadêmica · doi:10.35265/2236-6717-235-12651 · Cited by 3
Preoperative management of medications for psychiatric disorders
Robles, C. R. F., Fernandez-Robles, C. G., & Oprea, A. D. (2024) · Panminerva Medica · doi:10.23736/s0031-0808.24.05151-6
Reiter, M., Reiter, A., Towns, T., & Bessa, Y. (2024) · Open Journal of Social Sciences · doi:10.4236/jss.2024.127008
Relationship between selective serotonin reuptake inhibitors and hypertension
Samarraae, A. A. S. A. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i3.2716
Mental Health Disorders: An Overlooked Aspect of Chronic Kidney Disease in Older Adults
Corona, A. G. D. L., Wang, L. G., & Brogan, M. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-68460-9_4
Self-citationFish, A., Pober, B. R., & Thom, R. P. (2024) · Springer eBooks · doi:10.1007/978-3-031-76269-7_3
Fisher, K. G., Leach, O. K., Greaney, J. L., Alexander, L. M., & Kenney, W. L. (2026) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00147.2026
Effects of Chronic Pain Medications on Cardiovascular Health: A Narrative Review
Kent, A., Toubasi, A. Y. M., Myles, A., Dua, A., Arora, V., Dong, Y., & Sun, Z. (2026) · Cureus · doi:10.7759/cureus.113644
“A 2017 meta-analysis of 23 RCTs found that SSRIs did not affect BP, while SNRIs led to a slight elevation in SBP and DBP with statistical significance compared with SSRIs [46].”
Alcalá, J. Á., Peña, M. J., & Roca, M. (2026) · Clinical Drug Investigation · doi:10.1007/s40261-026-01605-4
Interpreting the serotonin blood pressure paradox: An updated integrative framework for hypertension
Oleshchuk, O., Chornomydz, Y., & Чорномидз, А. В. (2026) · Romanian Journal of Cardiology · doi:10.2478/rjc-2026-0032
Metadata
- Authors
- Zhong, Z., Wang, L., Wen, X., Liu, Y., Fan, Y., & Liu, Z.
- Affiliations
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Guangdong General Hospital (CN)
- Guangzhou First People's Hospital (CN)
- Sun Yat-sen University (CN)
- Corresponding author
- Liu, Zhonglin
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2017-11
- Volume
- Volume 13
- Pages
- 2781-2796
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC5683798
- OpenAlex
- W2767504574
- Cited by
- 46
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 3
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Science and Technology Planning Project of Guangdong Province (KLB09001, 2014A020212148)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, blood pressure, depression treatment, antidepressants, systolic blood pressure, diastolic blood pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.